Carisma Therapeutics Inc. Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 35 trades in Carisma Therapeutics Inc. (NASDAQ: CARM) since 2014, across 2 members, worth an estimated $1.2M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 20 buys against 15 sells, a modestly buy-led skew, with Democratic members responsible for 14% of the trades and Republican members 86%. The most recent disclosure shown was filed December 2025, and Michael T. McCaul has filed the most CARM transactions among those shown, with 2. Other recent filers include Ro Khanna. One notable disclosed move was a sale by Ro Khanna on August 26, 2025, down 100.0% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Carisma Therapeutics Inc. (CARM) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Carisma Therapeutics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Michael T. McCaul House | Dec 9, 2025 | Nov 24, 2025 | 15 days | BUY |  $100,001 - $250,000 | -99.77% | |
Michael T. McCaul House | Nov 10, 2025 | Oct 17, 2025 | 24 days | SELL | $1,001 - $15,000 | -99.73% | |
 Ro Khanna House | Sep 9, 2025 | Aug 26, 2025 | 14 days | SELL | $1,001 - $15,000 | -99.96% |
Carisma Therapeutics (CARM) congressional trading FAQ
Can members of Congress legally trade Carisma Therapeutics (CARM) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Carisma Therapeutics (CARM), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Carisma Therapeutics (CARM) trades public?
Yes. Every congressional trade in Carisma Therapeutics (CARM) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Carisma Therapeutics (CARM)?
Members of Congress have disclosed 35 trades in Carisma Therapeutics (CARM) worth $1.2M across 2 members, according to public STOCK Act filings.
Which members of Congress have traded Carisma Therapeutics (CARM)?
Recent and active filers of Carisma Therapeutics (CARM) disclosures include Michael T. McCaul, Ro Khanna. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Carisma Therapeutics (CARM) more?
Across disclosed Carisma Therapeutics (CARM) trades, 14% were by Democrats and 86% by Republicans, led by Republicans (86%).
What is the most recent congressional Carisma Therapeutics (CARM) trade?
The most recent disclosed Carisma Therapeutics (CARM) trade was a purchase by Michael T. McCaul, filed Dec 8, 2025.
Browse all stocks Congress tradesCongressional trading overviewCarisma Therapeutics (CARM) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.